Pharma News

After posting positive late-stage results for its rare blood disease drug, Sanofi has been handed a priority review from the FDA for sutimlimab.

After getting the cold shoulder from regulators over its filing for CAR-T candidate ide-cel earlier this week, Bristol Myers Squibb at least has good news now for one of the products it acquired throu...

NantKwest announced plans for a Phase 2, randomized, open-label study to evaluate the efficacy and safety of their combination immunotherapy.

Privately-held biopharma Exvastat (Ireland) Ltd has won a 3.

Last September, Johnson & Johnson said prostate cancer med Erleada had “barely missed” showing it could extend the lives of patients with nonmetastatic castration-resistant disease.

Researchers from Bar-Ilan University have developed new methodologies to produce powerful, environmentally friendly disinfectants based on tap water that can eliminate bacteria and kill viruses, inclu...

Patients with follicular lymphoma will now get NHS-funded treatment with Roche's Gazyvaro (binutuzumab)/bendamustine in England and Wales after cost regulators published guidelines backing...

BEIJING, Xinhua -- Chinese researchers have identified a gene that is related to arterial aging in primates.

The National Institute for Health and Care Excellence (NICE) has published guidance recommending the use of Pfizer's Lorviqua (lorlatinib) for a certain form of lung cancer on the ...

A Stanford research team has developed a way to boost the effectiveness of the insulin injections people with diabetes routinely take to control their blood sugar.

The U.

NORTH CHICAGO, May 8, 2020 /PRNewswire/ -- AbbVie (NYSE.